Changes in GM1 ganglioside content and localization in cholestatic rat liver.
(Glyco)sphingolipids (GSL) are believed to protect the cell against harmful environmental factors by increasing the rigidity of plasma membrane. Marked decrease of membrane fluidity in cholestatic hepatocytes was described but the role of GSL therein has not been investigated so far. In this study, localization in hepatocytes of a representative of GSL, the GM1 ganglioside, was compared between of rats with cholestasis induced by 17alpha-ethinylestradiol (EE) and vehicle propanediol treated or untreated animals. GM1 was monitored by histochemical reaction employing cholera toxin B-subunit. Our findings in normal rat liver tissue showed that GM1 was localized in sinusoidal and canalicular hepatocyte membranes in both peripheral and intermediate zones of the hepatic lobules, and was nearly absent in central zones. On the contrary, in EE-treated animals GM1 was also expressed in central lobular zones. Moreover, detailed densitometry analysis at high magnification showed greater difference of GM1 expression between sinusoidal surface areas and areas of adjacent cytoplasm, caused as well by increased sinusoidal staining in central lobular zone as by decreased staining in cytoplasm in peripheral zone. These differences correlated with serum bile acids as documented by linear regression analyses. Both GM1 content and mRNA corresponding to GM1-synthase remained unchanged in livers; the enhanced expression of GM1 at sinusoidal membrane thus seems to be due to re-distribution of cellular GM1 at limited biosynthesis and could be responsible for protection of hepatocytes against harmful effects of bile acids accumulated during cholestasis.
Jirkovská
Marie
M
Institute of Histology and Embryology, Prague, Czech Republic.
Majer
Filip
F
Smídová
Jaroslava
J
Stríteský
Jan
J
Shaik
Gouse Mohiddin
GM
Dráber
Petr
P
Vítek
Libor
L
Marecek
Zdenek
Z
Smíd
Frantisek
F
D000818:Animals; D015415:Biomarkers / Q000097:blood; D002779:Cholestasis / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology; D002784:Cholesterol / Q000097:blood; D004997:Ethinyl Estradiol; D005260:Female; D005677:G(M1) Ganglioside / Q000378:metabolism*; D022781:Hepatocytes / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D008099:Liver / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D011409:Propylene Glycols / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D012016:Reference Values
D015415:Biomarkers; D011409:Propylene Glycols; D005677:G(M1) Ganglioside; D004997:Ethinyl Estradiol; D002784:Cholesterol